Illumina announces FDA-approved NGS cancer companion test kit

Friday, 07 July, 2017

Illumina has announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit.

This kit is intended to be used on the Illumina MiSeqDx System and enables laboratories to help clinicians identify which patients are eligible for treatment of metastatic colorectal cancer with Vectibix (panitumumab).

As the first monoclonal anti-epidermal growth factor receptor (EGFR) antibody approved by the FDA for use in combination with FOLFOX for first-line treatment for patients with wild-type RAS metastatic colorectal cancer (mCRC), Vectibix represents an innovative treatment option for these patients. The improvement of both overall survival and progression-free survival seen with Vectibix in combination with FOLFOX in patients with wild-type RAS mCRC highlights the importance of expanded biomarker screening to optimise cancer treatment planning.

“Together with Amgen, we’ve developed a companion diagnostic test kit that interrogates 56 variants across the KRAS and NRAS genes in order to establish mutant status in a single test. Through the Extended RAS Panel, clinicians will be able to identify patients with wild-type RAS genes who may benefit from treatment with Vectibix,” shared Garret Hampton, PhD, Executive Vice President, Clinical Genomics at Illumina.

“As we expand our understanding of the genomic drivers of cancer, next-generation sequencing has the potential to transform cancer therapeutics by informing development of targeted therapies and by delivering integrated testing platforms to identify the right therapy for the right patient,” said Francis deSouza, President and CEO of Illumina.

Related News

New tissue-imaging tech could enable real-time diagnostics

A new microscope system can image living tissue in real time and in molecular detail, without any...

Monash scientists get US patent for malaria diagnostic technique

A research collaboration headed by a Monash chemist has received a US patent for a diagnostic...

Monash researchers built own microscope to decipher superbugs

A hand-made super-microscope has enabled Monash researchers to decipher how bacteria are able to...

  • All content Copyright © 2018 Westwick-Farrow Pty Ltd